Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0025202 (
melanoma
)
69,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The control of melanin production,
tyrosinase
activity, and cell replication by melanocyte-stimulating hormone (MSH) and cyclic AMP (cAMP) was examined in differentially metastasizing B16 mouse
melanoma
variants. In B16-F1 cells (low metastatic potential), MSH or cAMP greatly elevated
tyrosinase
activity and melanin content while inhibiting cell replication. The same parameters in B16-F5 cells (intermediate metastatic potential) were altered to a much lesser degree, whereas B16-F10 cells (high metastatic potential) were not significantly affected by MSH or cAMP. Therefore, a correlation exists between loss of hormonal regulation and increased metastatic potential.
...
PMID:Control of melanogenesis in mouse melanoma cells of varying metastatic potential. 21 Feb 94
The acute in vitro action of adrenocorticotropin (ACTH) and corticosterone alone and in combination were determined in the Harding-Passey (HP)
melanoma
grown in vivo. Hormone treated
melanoma
dice (5--240 min) were analyzed for
tyrosinase
activity, cyclic AMP (cAMP) and cyclic GMP (cGMP). ACTH elevated cAMP and cGMP levels 20- and 13-fold, respectively, in the HP
melanoma
. However, these large increases in cyclic nucleotide levels were accompanied by only a 49% increase in
tyrosinase
activity. Corticosterone elicited a similar response. ACTH plus corticosterone produced an early cAMP and cGMP peak followed by depression. ACTH plus corticosterone stimulated
tyrosinase
activity coincident with the early cyclic nucleotide peak followed by a drop in
tyrosinase
activity which was subsequently elevated. The results indicate that neither cAMP nor cGMP are the sole modulators of
tyrosinase
activity and suggest the interaction of ACTH, corticosterone and cyclic nucleotides in the regulation of
melanoma
tyrosinase
activity.
...
PMID:Interaction of ACTH, corticosterone and cyclic nucleotides in Harding-Passey melanoma melanogenesis. 21 Jul 23
The decrease in
tyrosinase
activity following incubation of melanosomes isolated from mouse
melanoma
with dopa appeared to be related to the degree of in vitro melanization of melanosomes caused by incubation with dopa. The inactivation similarly occurred in the dopa-
tyrosinase
reaction system containing ascorbic aicd, although in the presence of ascorbic acid the dopa-quinone is immediately converted back to dopa and therefore melanin formation does not take place. The mode of inactivation of
tyrosinase
in melanosomes appeared to be similar to the reaction inactivation which is known to occur in the reaction of plant plant
tyrosinase
. Superoxide anion (O-2) and singlet oxygen (1O2) were estimated but undetectable during the dopa-
tyrosinase
reaction. Thus the inactivation of
tyrosinase
is not caused by the reaction products or the oxygen radicals.
...
PMID:Nature of tyrosinase inactivation in melanosomes. 21 76
We have studied the effects of theophylline treatment on pigmentation characteristics and growth of two B16
melanoma
cell lines, HFH-18 and P/140. Cell counts of control and theophylline-treated cultures confirmed that the drug inhibits cell growth. Light and electron microscope cytochemistry with the L-dopa reaction indicated that the two cell lines differ in their ability to transfer Golgi-associated
tyrosinase
to developing premelanosomes. The results of these experiments, considered with results of electrophoretic analyses and activity measurements by the Pomerantz method, also provide evidence that increased
tyrosinase
synthesis occurs in response to theophylline treatment. In addition, results indicate that theophylline induces changes in the rate of synthetic or degradative posttranslational modification of
tyrosinase
. Measurements of intracellular cyclic AMP levels by radioimmunoassay in control cultures and in theophylline- and alpha-MSH-treated cultures were made. Although the hormone induced spectacular increases in cyclic AMP levels, theophylline produced no detectable change. These results indicate that theophylline differs from alpha-MSH because theophylline-induced changes in pigmentation may not require the participation of intracellular cyclic AMP.
...
PMID:Tyrosinase maturation and pigment expression in B16 melanoma: relation to theophylline treatment and intracellular cyclic AMP. 22 87
The acute in vitro action of ACTH and corticosterone individually and in combination were determined in the B-16
melanoma
grown in vivo. ACTH elevated levels 10-fold while
tyrosinase
activity generally was depressed. Corticosterone depressed cAMP levels and
tyrosinase
activity. ACTH in the presence of corticosterone produced a coincident peak in
tyrosinase
activity and cAMP levels followed by a depression of enzymatic activity. The results demonstrate that cAMP is not the sole modulator of
tyrosinase
activity and that ACTH, corticosterone and cAMP interact in the regulation of B-16
melanoma
tyrosinase
activity.
...
PMID:Effect of ACTH and corticosterone on melanogenesis and cyclic nucleotide levels in the B-16 melanoma. 22 4
In vivo inhibition of the DOPA-oxydase activity of the soluble
tyrosinase
fraction of melanotic hamster
melanoma
is found after i.p. administration of diethyldithiocarbamate, with considerable increase in the content of SH-groups which probably play the role of free radical scavengers.
...
PMID:In vivo inhibition of the tyrosinase of hamster melanoma with sodium diethyldithiocarbamate. 22 16
A variant of B-16 F1 mouse
melanoma
was selected for its ability to survive and replicate in the presence of melanocyte-stimulating hormone (MSH). Although the variant (MR-4) was completely resistant to growth inhibition of MSH, cyclic AMP was still able to block cell replication. Tyrosinase activity in MR-4 cells was considerably lower than in B-16 F1 cells. MSH induced a two fold to three-fold increase in
tyrosinase
activity in both cell types, but the absolute activity in MR-4 remained significantly less than in the parental cells. MR-4 cells were also found to have a markedly depressed cyclic AMP-dependent protein kinase activity relative to B-16 F1 cells. The protein kinase from both cell types was stimulated by cyclic AMP, but the level of MR-4 kinase activity at maximal cyclic AMP concentrations remained considerably lower than B-16 F1 kinase activity under the same conditions. In both cell types adenylate cyclase activity was markedly stimulated by MSH. When equal numbers of viable F1 and MR-4 cells were injected subcutaneously into C57/B1 mice, the MR-4 cells formed tumors earlier and killed the host sooner than the parental F1 cells. We conclude that the biochemical alteration which allows MR-4 cells to replicate in the presence of MSH is a low level of
tyrosinase
activity, which in turn may be the result of low cyclic AMP-dependent protein kinase activity.
...
PMID:Isolation and characterization of a variant of B16-mouse melanoma resistant to MSH growth inhibition. 23 92
Three cases of metastatic malignant lesions are presented. By conventional pathologic examination these lesions were diagnosed as undifferentiated carcinomas. They were studied using a chimpanzee antiserum specific for human
melanoma
-associated antigens. In each case, cells from the tumor were reactive with the anti-
melanoma
antiserum. The tumors were also studied using the DOPA test. All three tumors were positive in the DOPA test, suggesting the presence of
tyrosinase
within the tumor cells. The results suggest that serologic identification of
melanoma
may provide a rapid, inexpensive means for tumor diagnosis.
...
PMID:Immunodiagnosis of melanoma using chimpanzee antihuman melanoma antiserum. 32 27
Conley et al., in 1971, described a special type of
melanoma
characterized by a superficial melanic lesion at the onset; repeated local relapses as subcutaneous tumorations with an histological picture closely resembling an atypical fibroxantoma or fibrosarcoma. After a review of all the published material the autors presents a personal case with the clinical, histological and evolutive characteristics of this disease. The most interesting findings of the published case are the following: The special stains for the melanocytes (silver stain, Dopa,
tyrosinase
and cholinesterase) were all negative. There was an intense positivity for the lisosomal enzymes (non specific sterases, and acid phosphatases). The ultrastructural study of the tumoral tissues as well as the cells of cultures showed abundant cells with tumoral aspects, with prominent nucleoli somewhat dilated granular endoplasmic reticulum, myelin-like figures, lipidic vacuoles and abundant lisosomes. No melanosomes or premelanosomes were observed. Beside these tumoral cells abundant typical fibroblastic elements were found. There was a great amount of collagen fibers with periodicity superior to the normal. The conclusion is that the desmoplastic
melanoma
must be considered as a tumor of mesenchimatous origin intervening in its development multiple local and general factors.
...
PMID:[Desmoplastic melanoma]. 34 19
Disc gel electrophoresis of
tyrosinase
solubilized by sodium deoxycholate (DOC) from the particle fraction of B16 mouse
melanoma
was carried out in the presence of DOC. A single
tyrosinase
band, considered to be T3, was detected at the Rx value of 0.60 against Coomassie brilliant blue. The T3 band which is located between T1 and T2 seems to be distinct from the soluble forms of
tyrosinase
. Its molecular weight was estimated to be 102,000. When treated with proteolytic enzymes or refrigerated, the T3 molecule converted into a molecule whose mobility was equivalent tothat of T1.
...
PMID:Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase. 40 50
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>